MMPI-2 validity, clinical and content scales, and the Fake Bad Scale for personal injury litigants claiming idiopathic environmental intolerance

被引:7
作者
Staudenmayer, Herman [1 ]
Phillips, Scott
机构
[1] Behav Med Clin, Denver, CO 80222 USA
[2] Univ Colorado, Hlth Sci Ctr, Denver, CO USA
[3] NewFields, Denver, CO USA
关键词
MMPI-2; IEI; idiopathic environmental intolerances; forensic assessment; functional somatic syndromes;
D O I
10.1016/j.jpsychores.2006.01.013
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: Idiopathic environmental intolerance (IEI) is a descriptor for nonspecific complaints that are attributed to environmental exposure. Methods: The Minnesota Multiphasic Personality Inventory 2 (MMPI-2) was administered to 50 female and 20 male personal injury litigants alleging IEI. Results: The validity scales indicated no overreporting of psychopathology. Half of the cases had elevated scores on validity scales suggesting defensiveness, and a large number had elevations on Fake Bad Scale (FBS) suggesting overreporting of unauthenticated symptoms. The average T-score profile for females was defined by the two-point code type 3-1 (Hysteria-Hypochondtiasis), and the average T-score profile for males was defined by the three-point code type 3-1-2 (Hysteria, Hypochondriasis-Depression). On the content scales, Health Concerns (HEA) scale was significantly elevated. Conclusion: Idiopathic environmental intolerance litigants (a) are more defensive about expressing psychopathology, (b) express distress through somatization, (c) use a self-serving misrepresentation of exaggerated health concerns, and (d) may exaggerate unauthenticated symptoms suggesting malingering. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:61 / 72
页数:12
相关论文
共 82 条
  • [1] AAAAI Board Directors, 1999, J ALLERGY CLIN IMMUN, V103, P36
  • [2] PSYCHOLOGICAL-FACTORS ASSOCIATED WITH PRIMARY FIBROMYALGIA SYNDROME
    AHLES, TA
    YUNUS, MB
    RILEY, SD
    BRADLEY, JM
    MASI, AT
    [J]. ARTHRITIS AND RHEUMATISM, 1984, 27 (10): : 1101 - 1106
  • [3] American Cancer Society, 1999, ACR STAND, P1
  • [4] [Anonymous], 1996, Neurology, V47, P592
  • [5] [Anonymous], MMPI MMPI 2 MMPI A C
  • [6] [Anonymous], 1996, REGUL TOXICOL PHARM
  • [7] [Anonymous], CHEM SENSITIVITY
  • [8] An MMPI-2 infrequent response scale for use with psychopathological populations: The infrequency-psychopathology scale, F(p)
    Arbisi, PA
    BenPorath, YS
    [J]. PSYCHOLOGICAL ASSESSMENT, 1995, 7 (04) : 424 - 431
  • [9] Ashford N., 1998, Chemical exposures: low levels and high stakes
  • [10] SOMATIZATION AND MEDICALIZATION IN THE ERA OF MANAGED CARE
    BARSKY, AJ
    BORUS, JF
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (24): : 1931 - 1934